Y-Intercept (HK)’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.07M Sell
3,943
-21,495
-84% -$6.06M 0.02% 975
2026
Q2
$7.01M Buy
25,438
+13,232
+108% +$3.74M 0.14% 178
2026
Q1
$3.26M Buy
+12,206
New +$3.38M 0.06% 501
2025
Q4
– Sell
-7,738
Closed -$2.23M – 1598
2025
Q3
$2.23M Sell
7,738
-962
-11% -$285K 0.05% 554
2025
Q2
$2.88M Buy
+8,700
New +$2.8M 0.07% 440
2025
Q1
– Sell
-15,760
Closed -$4.35M – 1246
2024
Q4
$4.35M Buy
15,760
+7,046
+81% +$2.25M 0.29% 66
2024
Q3
$3.02M Sell
8,714
-5,559
-39% -$1.91M 0.18% 119
2024
Q2
$4.72M Buy
+14,273
New +$4.92M 0.26% 74
2023
Q2
– Sell
-30,314
Closed -$7.75M – 1317
2023
Q1
$7.75M Buy
+30,314
New +$8.83M 0.9% 1
2022
Q4
– Sell
-6,524
Closed -$1.81M – 1036
2022
Q3
$1.81M Buy
+6,524
New +$1.84M 0.18% 161
2022
Q1
– Sell
-13,984
Closed -$3.21M – 751
2021
Q4
$3.21M Buy
13,984
+3,977
+40% +$845K 0.76% 13
2021
Q3
$2M Buy
10,007
+5,473
+121% +$1.19M 0.36% 60
2021
Q2
$1.08M Buy
4,534
+2,588
+133% +$646K 0.27% 86
2021
Q1
$478K Buy
+1,946
New +$434K 0.13% 267

Other funds holding CI

Y-Intercept (HK)'s CI Position: Q3 2026 in Review

Y-Intercept (HK) reduced its Cigna (CI) stake by 84% in Q3 2026, selling an estimated $6.06M and leaving 3,943 shares worth $1.07M. The position accounts for 0.02% of the portfolio, ranked #975.

Y-Intercept (HK) first reported a position in CI in Q1 2021 and has held it in 14 quarters since. The position peaked at $7.75M in Q1 2023. 1,059 funds tracked by Wall St. Rank hold CI as of Q3 2026.

  • Y-Intercept (HK) held 3,943 shares of Cigna worth $1.07M as of Q3 2026.
  • Y-Intercept (HK) sold 21,495 Cigna shares in Q3 2026, an estimated $6.06M.
  • Cigna made up 0.02% of Y-Intercept (HK)'s portfolio in Q3 2026, its #975 holding.
  • Y-Intercept (HK) first reported a position in Cigna in Q1 2021 and has held it in 14 quarters since.
  • Y-Intercept (HK)'s Cigna position peaked at $7.75M in Q1 2023.
  • 1,059 funds tracked by Wall St. Rank held Cigna as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.